Saptaparna Dasgupta, Bennett University Rituximab being a revolutionary monoclonal antibody, owing up to the mode of action as a potent therapeutic in targeting CD20 cells, has a strong impact on autoimmune health, including systemic lupus erythematosus. Thrombocytopenia, a rare illness, following rituximab is seen to give rise to haematological malignancy. As autoimmune disorders are rare […]
Saptaparna Dasgupta, Bennett University A recently published new study states that both the Pfizer-BioNTech and Moderna COVID-19 vaccine immune system reactions have proved to offer long-lasting protection against COVID-19. mRNA vaccines have created more and better germinal centre B cell responses, thus indicating that the immunity system would be much more impactful and offer long-lasting […]
Soumya Shraddhya Paul, Amity University Noida For a very long time, monoclonal antibodies have been used in various fields (cancer studies) but currently, they are being used to counteract the effects of SARS-CoV-2 and its variant by being an active compound in the vaccine as well as therapeutic drugs. Hence, to understand B cell genomics […]
